3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
63
Carcinoma, Intraductal, Noninfiltrating
8
Breast Carcinoma In Situ
6
Neoplasms
4
Breast Neoplasms, Male
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Infertility
2
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pinealoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Medulloblastoma
1
Inflammatory Breast Neoplasms
1
Hypogonadism
1
Hyperglycemia
1
Hot Flashes
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
3
Specimen Handling
3
dabrafenib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
cobimetinib
1
Vemurafenib
1
Thyrotropin Alfa
1
Sodium Iodide
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-124
1
High-Energy Shock Waves
1
Glycoprotein Hormones, alpha Subunit
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Follicular
×
Tamoxifen
×
1 year
×
Clear all
No trials found.